Botulinum type A toxin (BTA) is an orphan drug used to treat several disorders of muscle spasticity. We report the first known case of systemic botulism-like syndrome induced by BTA therapy which resulted in respiratory arrest. Clinicians should be aware that systemic effects may occur with localized BTA therapy and may be life-threatening.
|Idioma original||English (US)|
|Número de páginas||1|
|Publicación||Veterinary and Human Toxicology|
|Estado||Published - 2000|
ASJC Scopus subject areas
- Health, Toxicology and Mutagenesis